From pg 74 of the report: Another product to be mentioned,...

From pg 74 of the report:

Another product to be mentioned, although it is not a visual assessment tool,
is TruScreen Ultra (TruSreen Group Limited), an opto-electrical device, with
an AI-based algorithm embedded. This technology uses a single use sensor to
interface with the cervix, enabling the assessment of different features of the
cells, including electrical properties. Then, through its two-state algorithm,
the test is classified as normal or abnormal. According to the information
provided by the manufacturer, the algorithm was trained and validated in
over 40,000 women, in multiple settings, including some LMIC countries,
most significantly in China.